Ischemic stroke in the setting of supratherapeutic International Normalized Ratio following coronavirus disease 2019 infection: a case report
ConclusionsThis case report highlights the potential for thromboembolic events, including stroke, in patients with COVID-19 infection, even when receiving therapeutic anticoagulation therapy. Healthcare providers should be vigilant for signs of thrombosis in COVID-19 patients, particularly those with pre-existing risk factors. Further research is necessary to understand the pathophysiology and optimal management of thrombotic complications in COVID-19 patients.
Source: Journal of Medical Case Reports - Category: General Medicine Source Type: research
More News: Brain | Coronavirus | Coumadin | COVID-19 | General Medicine | Ischemic Stroke | Neurology | Pneumonia | Respiratory Medicine | SARS | Stroke | Study | Thrombosis | Warfarin